Bio-Gene Technology Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BGT.AX research report →
Price Chart
About the company
Bio-Gene Technology Limited, an agricultural technology firm based in Australia, focuses on the development and commercialization of insecticides and pesticides. These solutions are designed for a range of uses, encompassing animal health, crop protection, public health, and consumer applications. The company's key products include Flavocide, an insecticide utilizing beta-triketone technology, and Qcide, a natural oil derived from a specific cultivar of eucalyptus cloeziana.
- CEO
- Timothy Owen Grogan
- IPO
- 2017
- Employees
- 5
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on BGT.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.86M
- P/E
- -2.54
- PEG
- -0.05
- P/S
- 0.00
- P/B
- 4.70
- EV/EBITDA
- -1.23
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -140.35%
- ROIC
- -196.64%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-245,779+18.5%
- Op Income
- $-3,066,911
- Net Income
- $-2,584,468-7.3%
- EPS
- $-0.01+6.2%
- OCF Growth
- +7.7%
- FCF Growth
- +7.9%
- 52W High
- $0.06
- 52W Low
- $0.02
- 50D MA
- $0.02
- 200D MA
- $0.03
- Beta
- 0.78
- RSI (14)
- 38
- Avg Volume
- 421.53K
No earnings-call transcripts are available for BGT.AX yet.
- Free Float
- 90.0%
- Shares Outstanding
- 270.24M
- Float Shares
- 243.25M
Our BGT.AX coverage
Recent articles, reports, and earnings notes.
No research on BGT.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BGT.AX report →